Lifeworks Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,372
Closed -$463K 324
2025
Q1
$463K Sell
6,372
-18,035
-74% -$1.42M 0.08% 187
2024
Q4
$1.76M Buy
24,407
+6,027
+33% +$457K 0.32% 85
2024
Q3
$1.5M Buy
18,380
+3,500
+24% +$304K 0.29% 94
2024
Q2
$1.58M Sell
14,880
-270
-2% -$25.9K 0.44% 67
2024
Q1
$1.47M Buy
15,150
+1,750
+13% +$154K 0.41% 71
2023
Q4
$1.05M Buy
+13,400
New +$913K 0.36% 81
2022
Q3
Sell
-17,660
Closed -$753K 148
2022
Q2
$753K Buy
17,660
+3,750
+27% +$179K 0.48% 73
2022
Q1
$748K Buy
13,910
+6,620
+91% +$385K 0.49% 73
2021
Q4
$524K Buy
+7,290
New +$457K 0.42% 72

Other funds holding LRCX

Lifeworks Advisors's LRCX Position: Q2 2025 in Review

Lifeworks Advisors sold out of Lam Research (LRCX) in Q2 2025, closing a stake of 6,372 shares — an estimated $463K sold.

Lifeworks Advisors first reported a position in LRCX in Q4 2021 and held it in 9 quarters. The position peaked at $1.76M in Q4 2024. 1,878 funds tracked by Wall St. Rank hold LRCX as of Q2 2025.

  • Lifeworks Advisors reported no remaining Lam Research position as of Q2 2025 after selling out during the quarter.
  • Lifeworks Advisors sold 6,372 Lam Research shares in Q2 2025, an estimated $463K.
  • Lifeworks Advisors first reported a position in Lam Research in Q4 2021 and held it in 9 quarters.
  • Lifeworks Advisors's Lam Research position peaked at $1.76M in Q4 2024.
  • 1,878 funds tracked by Wall St. Rank held Lam Research as of Q2 2025.

Based on Lifeworks Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.